Sonnet BioTherapeutics Holdings, Inc.
SONNDelisted Dec 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106838
Sonnet BioTherapeutics Holdings, Inc. was delisted on Dec 2, 2025; its insiders filed their last Form 4 on Dec 4, 2025; 27 institutions reported holding it in 13F filings for Q3 2025, worth $3.53M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Sonnet BioTherapeutics Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 10 | +10 |
| Shares | 0 | 38.3K | +38.3K |
| Value | $0 | $110.1K | +$110.1K |
New holders (10)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 19,049 | $55.0K | 0.00% |
| Vanguard Group Inc | 14,626 | $41.9K | 0.00% |
| UBS Group AG | 3,713 | $10.6K | 0.00% |
| BlackRock Inc. | 594 | $1.70K | 0.00% |
| Morgan Stanley | 142 | $407 | 0.00% |
| Bank of America Corp | 94 | $270 | 0.00% |
| Advisor Group Holdings, Inc. | 45 | $129 | 0.00% |
| Wells Fargo & Company | 11 | $32 | 0.00% |
| IFP Advisors, Inc | 6 | $17 | 0.00% |
| Citigroup Inc | 3 | $9 | 0.00% |
Sold out (0)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.